Alopecia Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 – 2032
The Global Alopecia Market was valued at USD 8.7 billion in 2023 and is anticipated to grow at a CAGR of 8.1% between 2024 and 2032. The market expansion is primarily driven by the rising prevalence of alopecia and increased awareness of available treatment options. Various factors, such as genetic predispositions, hormonal changes, autoimmune conditions, and environmental stressors, contribute to the growing number of alopecia cases. Additionally, lifestyle factors like poor diet and stress further aggravate hair loss, pushing more individuals to seek effective treatments. With millions affected by alopecia globally, the demand for both pharmaceutical treatments and advanced hair restoration technologies is on the rise.
This growing patient base propels market growth, as more people explore treatment options to combat hair loss. In terms of disease type, the market is segmented into androgenetic alopecia, alopecia areata, and other forms of hair loss. Androgenetic alopecia, commonly known as pattern baldness, accounted for the largest share in 2023, generating around USD 4.8 billion in revenue. Affecting a significant percentage of men, particularly as they age, androgenetic alopecia remains a dominant driver of market demand for treatments.
When categorized by treatment type, pharmaceuticals took the lead in 2023, claiming 48.8% of the total market share. Widely recognized for their effectiveness, pharmaceutical treatments—both topical and oral—are often the first choice for treating alopecia due to their non-invasive nature and proven ability to stimulate hair regrowth. Their accessibility and ease of use make them the most preferred option among patients. North America alopecia market, which generated USD 3.2 billion in revenue in 2023, is expected to grow at a 7.7% CAGR through 2032. The high incidence of alopecia in the region, particularly androgenetic alopecia, drives the demand for innovative and effective treatments.With a large portion of the population affected by hair loss, North America continues to be a key market contributing to overall industry growth.
This growing patient base propels market growth, as more people explore treatment options to combat hair loss. In terms of disease type, the market is segmented into androgenetic alopecia, alopecia areata, and other forms of hair loss. Androgenetic alopecia, commonly known as pattern baldness, accounted for the largest share in 2023, generating around USD 4.8 billion in revenue. Affecting a significant percentage of men, particularly as they age, androgenetic alopecia remains a dominant driver of market demand for treatments.
When categorized by treatment type, pharmaceuticals took the lead in 2023, claiming 48.8% of the total market share. Widely recognized for their effectiveness, pharmaceutical treatments—both topical and oral—are often the first choice for treating alopecia due to their non-invasive nature and proven ability to stimulate hair regrowth. Their accessibility and ease of use make them the most preferred option among patients. North America alopecia market, which generated USD 3.2 billion in revenue in 2023, is expected to grow at a 7.7% CAGR through 2032. The high incidence of alopecia in the region, particularly androgenetic alopecia, drives the demand for innovative and effective treatments.With a large portion of the population affected by hair loss, North America continues to be a key market contributing to overall industry growth.
Report Content
CHAPTER 1 METHODOLOGY & SCOPE
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Industry 360° synopsis
CHAPTER 3 INDUSTRY INSIGHTS
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of alopecia
3.2.1.2 Technological advancements in treatment regimes
3.2.1.3 Growing awareness about alopecia treatment options
3.2.1.4 Rising demand for drugs and treatments
3.2.2 Industry pitfalls & challenges
3.2.2.1 Regulatory barriers in treatment access
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Consumer preference
3.7 Porter’s analysis
3.8 PESTEL analysis
3.9 Future market trends
3.10 Gap analysis
CHAPTER 4 COMPETITIVE LANDSCAPE, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
CHAPTER 5 MARKET ESTIMATES AND FORECAST, BY DISEASE TYPE, 2021 – 2032 ($ MN)
5.1 Key trends
5.2 Androgenetic alopecia
5.3 Alopecia areata
5.4 Other disease types
CHAPTER 6 MARKET ESTIMATES AND FORECAST, BY TREATMENT TYPE, 2021 – 2032 ($ MN)
6.1 Key trends
6.2 Pharmaceutical
6.2.1 Topical
6.2.2 Oral
6.3 Device
6.3.1 Laser cap
6.3.2 Laser comb
6.3.3 Laser helmet
6.4 Other treatments
CHAPTER 7 MARKET ESTIMATES AND FORECAST, BY GENDER, 2021 – 2032 ($ MN)
7.1 Key trends
7.2 Male
7.3 Female
CHAPTER 8 MARKET ESTIMATES AND FORECAST, BY SALES CHANNEL, 2021 – 2032 ($ MN)
8.1 Key trends
8.2 Prescription
8.3 OTC
CHAPTER 9 MARKET ESTIMATES AND FORECAST, BY END USE, 2021 – 2032 ($ MN)
9.1 Key trends
9.2 Dermatology clinics
9.3 Homecare settings
9.4 Other end-users
CHAPTER 10 MARKET ESTIMATES AND FORECAST, BY REGION, 2021 – 2032 ($ MN)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
CHAPTER 11 COMPANY PROFILES
11.1 Apira Science, Inc. (iGROW Laser)
11.2 Aurobindo Pharma
11.3 Bosley – Hair Restoration & Transplant
11.4 Cipla
11.5 Curallux, LLC
11.6 Dr. Reddy’s Laboratories Ltd.
11.7 Freedom Laser Therapy, Inc. (iRESTORE Hair Growth System)
11.8 Johnson & Johnson Services, Inc.
11.9 Lexington International., LLC
11.10 Merck KGaA
11.11 Pfizer Inc.
11.12 REVIAN, Inc.
11.13 Smart Graft
11.14 Sun Pharmaceuticals Industries Ltd.
11.15 Theradome Inc.
CHAPTER 1 METHODOLOGY & SCOPE
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Industry 360° synopsis
CHAPTER 3 INDUSTRY INSIGHTS
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of alopecia
3.2.1.2 Technological advancements in treatment regimes
3.2.1.3 Growing awareness about alopecia treatment options
3.2.1.4 Rising demand for drugs and treatments
3.2.2 Industry pitfalls & challenges
3.2.2.1 Regulatory barriers in treatment access
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Consumer preference
3.7 Porter’s analysis
3.8 PESTEL analysis
3.9 Future market trends
3.10 Gap analysis
CHAPTER 4 COMPETITIVE LANDSCAPE, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
CHAPTER 5 MARKET ESTIMATES AND FORECAST, BY DISEASE TYPE, 2021 – 2032 ($ MN)
5.1 Key trends
5.2 Androgenetic alopecia
5.3 Alopecia areata
5.4 Other disease types
CHAPTER 6 MARKET ESTIMATES AND FORECAST, BY TREATMENT TYPE, 2021 – 2032 ($ MN)
6.1 Key trends
6.2 Pharmaceutical
6.2.1 Topical
6.2.2 Oral
6.3 Device
6.3.1 Laser cap
6.3.2 Laser comb
6.3.3 Laser helmet
6.4 Other treatments
CHAPTER 7 MARKET ESTIMATES AND FORECAST, BY GENDER, 2021 – 2032 ($ MN)
7.1 Key trends
7.2 Male
7.3 Female
CHAPTER 8 MARKET ESTIMATES AND FORECAST, BY SALES CHANNEL, 2021 – 2032 ($ MN)
8.1 Key trends
8.2 Prescription
8.3 OTC
CHAPTER 9 MARKET ESTIMATES AND FORECAST, BY END USE, 2021 – 2032 ($ MN)
9.1 Key trends
9.2 Dermatology clinics
9.3 Homecare settings
9.4 Other end-users
CHAPTER 10 MARKET ESTIMATES AND FORECAST, BY REGION, 2021 – 2032 ($ MN)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
CHAPTER 11 COMPANY PROFILES
11.1 Apira Science, Inc. (iGROW Laser)
11.2 Aurobindo Pharma
11.3 Bosley – Hair Restoration & Transplant
11.4 Cipla
11.5 Curallux, LLC
11.6 Dr. Reddy’s Laboratories Ltd.
11.7 Freedom Laser Therapy, Inc. (iRESTORE Hair Growth System)
11.8 Johnson & Johnson Services, Inc.
11.9 Lexington International., LLC
11.10 Merck KGaA
11.11 Pfizer Inc.
11.12 REVIAN, Inc.
11.13 Smart Graft
11.14 Sun Pharmaceuticals Industries Ltd.
11.15 Theradome Inc.
